A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain

NCT ID
NCT07641517
Registry status
Recruiting
Study type
Interventional
Phase
Phase 2
Sponsor
Eli Lilly and Company
Conditions
Chronic Pain, Osteoarthritis, Knee

Overview

ClinicalTrials.gov lists this study as Recruiting.

Official title: Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY4065967 for the Treatment of Osteoarthritis

Enrollment: 150 participants (Estimated).

What is being studied

  • Drug: LY4065967
  • Drug: Placebo

Who may be eligible

Ages
40 Years to no maximum
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Have presence of index knee pain for more than 12 weeks at screening * Have an x-ray supporting diagnosis of osteoarthritis according to the American College of Rheumatology with a Kellgren-Lawrence grade 2 to 4 radiographic classification of index knee * Have a body mass index ≤40 kilograms per meter squared (kg/m²) (inclusive) * Have stable glycemic control as indicated by a glycated hemoglobin (HbA1c) less than or equal to 10 at time of screening Exclusion Criteria: * Are pregnant or breastfeeding * Have had a surgical procedure or therapeutic injection in the affected knee within 3 months prior to screening * Have presence of surgical hardware or other foreign body in the index knee * Have ongoing complex regional pain syndrome or other concurrent medical condition that could interfere with the evaluation of pain in the index knee. * Have had any joint replacement of the lower extremity, such as hip, knee or ankle, in the 6 months prior to screening * Have an abnormal blood pressure (BP) (systolic BP greater than 140 millimeters mercury (\>140 mm Hg) and diastolic BP\>90 mm Hg) at screening * Have history or current clinically significant cardiac disease, including arrhythmia, aortic aneurysm, heart failure, current electrolyte abnormalities, or any other conditions that could predispose to arrhythmia in the judgement of the investigator

Study locations

37 study locations are listed.

Recruiting site status is explicitly provided for 37 locations; 37 are listed as Recruiting.

Countries: Puerto Rico, United States

  • Alabama, United States: 1
  • Arizona, United States: 2
  • California, United States: 3
  • Connecticut, United States: 1
  • Florida, United States: 12
  • Georgia, United States: 1
  • Illinois, United States: 1
  • Louisiana, United States: 1
  • Massachusetts, United States: 2
  • Michigan, United States: 1
  • Missouri, United States: 2
  • New York, United States: 1
  • North Dakota, United States: 1
  • Ohio, United States: 1
  • Oklahoma, United States: 1
  • Pennsylvania, United States: 1
  • Texas, United States: 2
  • Washington, United States: 2

Sample of listed locations

  • Ponce Medical School Foundation Inc. — Ponce, 00716, Puerto Rico — Recruiting
  • Central Research Associates — Birmingham, Alabama, 35205, United States — Recruiting
  • Arizona Research Center — Phoenix, Arizona, 85053, United States — Recruiting
  • Synexus Clinical Research US, Inc. — Phoenix, Arizona, 85020, United States — Recruiting
  • Desert Oasis Healthcare Medical Group — Palm Springs, California, 92262, United States — Recruiting
  • Artemis Institute for Clinical Research — Riverside, California, 92503, United States — Recruiting
  • Artemis Institute for Clinical Research — San Diego, California, 92123, United States — Recruiting
  • CMR of Greater New Haven — Hamden, Connecticut, 06517, United States — Recruiting
  • Bradenton Research Center, Inc. — Bradenton, Florida, 34205, United States — Recruiting
  • Accel Research Sites - DeLand Clinical Research Unit — DeLand, Florida, 32720, United States — Recruiting
  • K2 MEDICAL Research THE VILLAGES — Lady Lake, Florida, 32159, United States — Recruiting
  • K2 Medical Research ORLANDO — Maitland, Florida, 32751, United States — Recruiting
  • Merritt Island Medical Research, LLC — Merritt Island, Florida, 32952, United States — Recruiting
  • New Horizon Research Center — Miami, Florida, 33165, United States — Recruiting
  • Suncoast Research Group — Miami, Florida, 33135, United States — Recruiting
  • Suncoast Clinical Research, Inc. — New Port Richey, Florida, 34652, United States — Recruiting
  • Renstar Medical Research — Ocala, Florida, 34470, United States — Recruiting
  • Precision Clinical Research — Sunrise, Florida, 33351, United States — Recruiting
  • Charter Research - Lady Lake — The Villages, Florida, 32162, United States — Recruiting
  • Conquest Research — Winter Park, Florida, 32789, United States — Recruiting
  • North Georgia Clinical Research — Woodstock, Georgia, 30189, United States — Recruiting
  • Northwestern University — Chicago, Illinois, 60611, United States — Recruiting
  • DelRicht Research — New Orleans, Louisiana, 70115, United States — Recruiting
  • Lucida Clinical Trials — New Bedford, Massachusetts, 02740, United States — Recruiting
  • MedVadis Research Corporation — Waltham, Massachusetts, 02451, United States — Recruiting

Study details

Start date
June 25, 2026
Primary completion date
April 1, 2027
Completion date
April 1, 2027
First posted
June 11, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07641517
Registry last updated
September 4, 2026
QualifiedStudies registry data refreshed
October 5, 2026
QualifiedStudies record fetched
October 5, 2026

View NCT07641517 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Knee Pain studies | Osteoarthritis studies | Clinical trial FAQ